Multiple Myeloma

Oncology·MeSH: Multiple Myeloma

Prevalence

17.0 / 100K

Incidence

7.0 / 100K/yr

267 drugs in development·77 companies·144 clinical trials

Drug Pipeline by Phase

Approved(13)

Drug	Company
abecma	2seventy bio, Inc. (TSVT)
bortezomib	MAIA Biotechnology, Inc. (MAIA)
bortezomib	Aptinyx Inc. (APTX)
bortezomib	Mersana Therapeutics, Inc. (MRSN)
bortezomib	Teva Pharmaceutical Industries Limited (TEVA)
bortezomib	DR REDDYS LABORATORIES LTD (RDY)
carmustine	Amneal Pharmaceuticals, Inc. (AMRX)
clonoSEQ	Adaptive Biotechnologies Corp (ADPT)
cyclophosphamide	NEXUS BIOPHARMA INC (NEXS)
evomela	CASI Pharmaceuticals, Inc (DE) (CASI)
lenalidomide	Mylan II B.V. (MYL)
thalomid	CELGENE CORP /DE/ (CELG)
zoledronic acid	Amneal Pharmaceuticals, Inc. (AMRX)

Phase 3(68)

Drug	Company
anitocabtagene autoleucel	GILEAD SCIENCES, INC. (GILD)
Anitocabtagene Autoleucel	FATE THERAPEUTICS INC (FATE)
arlocabtagene autoleucel	Juno Therapeutics, Inc. (JUNO)
Arlocabtagene Autoleucel	BRISTOL MYERS SQUIBB CO (BMY)
AZD0120	ASTRAZENECA PLC (AZN)
azd0305	ASTRAZENECA PLC (AZN)
bb2121	CELGENE CORP /DE/ (CELG)
Bendamustine Hydrochloride	Filana Therapeutics Inc. (FLNA)
bl-8040 1.25 mg/kg + g-csf	BioLineRx Ltd. (BLRX)
bl-m24d1	TAKEDA PHARMACEUTICAL CO LTD (TKPHF)
bl-m24d1	Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK)
bortezomib	AbbVie Inc. (ABBV)
carfilzomib	Sanofi (SNY)
Carfilzomib	AbbVie Inc. (ABBV)
Carfilzomib	BRISTOL MYERS SQUIBB CO (BMY)
copal digital sphygmomamometer ua-550	Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK)
copal digital sphygmomanometer ua-510	Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK)
copal digital sphygmomanometer ua-535	Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK)
copal digital sphygmomanometer ua-540	Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK)
copal digital sphygmomanometer ua-560	Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK)
copal digital thermometer uf-10	Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK)
copal digital thermometer uf-12	Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK)
copal digital thermometer uf-22b	Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK)
copal ua-512 digital blood pressure monitor	Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK)
daratumumab	ASTRAZENECA PLC (AZN)
daratumumab	GH Research PLC (GHRS)
daratumumab	Juno Therapeutics, Inc. (JUNO)
daratumumab	REGENERON PHARMACEUTICALS, INC. (REGN)
Daratumumab	BRISTOL MYERS SQUIBB CO (BMY)
Daratumumab	Filana Therapeutics Inc. (FLNA)
daratumumab sc	GH Research PLC (GHRS)
descartes-11	Cartesian Therapeutics, Inc. (RNAC)
descartes-15	Cartesian Therapeutics, Inc. (RNAC)
digital sphygmomanometer model 7620	Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK)
elotuzumab	REGENERON PHARMACEUTICALS, INC. (REGN)
elotuzumab	AbbVie Inc. (ABBV)
elotuzumab	GH Research PLC (GHRS)
Elotuzumab	Merus N.V. (MRUS)
fludarabine	CELGENE CORP /DE/ (CELG)
Fosaprepitant	Merus N.V. (MRUS)
gamunex-c	Grifols S.A. (GRFS)
Iberdomide	BRISTOL MYERS SQUIBB CO (BMY)
idecabtagene vicleucel	CELGENE CORP /DE/ (CELG)
igi	TAKEDA PHARMACEUTICAL CO LTD (TKPHF)
igi	Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK)
IGI, 10%	Merus N.V. (MRUS)
induction therapy	GH Research PLC (GHRS)
Manufactured Anti-BCMA CAR-T cells	Filana Therapeutics Inc. (FLNA)
Melphalan	ENANTA PHARMACEUTICALS INC (ENTA)
Mezigdomide	BRISTOL MYERS SQUIBB CO (BMY)
montelukast	Sanofi (SNY)
Montelukast	Sanofi (SNY)
Pomalidomide	BeOne Medicines Ltd. (ONC)
Pomalidomide	AbbVie Inc. (ABBV)
Pomalidomide	BRISTOL MYERS SQUIBB CO (BMY)
Pomalidomide	Merus N.V. (MRUS)
regn5459	REGENERON PHARMACEUTICALS, INC. (REGN)
Selinexor	AbbVie Inc. (ABBV)
sonrotoclax	BeOne Medicines Ltd. (ONC)
tak-079	TAKEDA PHARMACEUTICAL CO LTD (TKPHF)
tak-079	Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK)
takeda medical digital sphygmomanometer	Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK)
talquetamab	GH Research PLC (GHRS)
Talquetamab	Merus N.V. (MRUS)
teclistamab	GH Research PLC (GHRS)
Teclistamab	Merus N.V. (MRUS)
teclistamab monotherapy	GH Research PLC (GHRS)
Tropisetron	Merus N.V. (MRUS)

Phase 2(57)

Drug	Company
allo-715	Allogene Therapeutics, Inc. (ALLO)
Bendamustine	FATE THERAPEUTICS INC (FATE)
Bortezomib	FATE THERAPEUTICS INC (FATE)
Bortezomib	Coeptis Therapeutics Holdings Inc. (COEP)
Busulfan	ENANTA PHARMACEUTICALS INC (ENTA)
Carfilzomib	Crinetics Pharmaceuticals, Inc. (CRNX)
Carfilzomib	FATE THERAPEUTICS INC (FATE)
CC-95266	Filana Therapeutics Inc. (FLNA)
cemsidomide	C4 Therapeutics, Inc. (CCCC)
Cilta-cel	Filana Therapeutics Inc. (FLNA)
Daratumumab	FATE THERAPEUTICS INC (FATE)
Daratumumab	Coeptis Therapeutics Holdings Inc. (COEP)
Daratumumab and Recombinant Human Hyaluronidase	FATE THERAPEUTICS INC (FATE)
Daratumumab and Recombinant Human Hyaluronidase	Crinetics Pharmaceuticals, Inc. (CRNX)
Daratumumab SC	FATE THERAPEUTICS INC (FATE)
elotuzumab	BRISTOL MYERS SQUIBB CO (BMY)
Elranatamab	Crinetics Pharmaceuticals, Inc. (CRNX)
Elranatamab	ENANTA PHARMACEUTICALS INC (ENTA)
EOS-448	iTeos Therapeutics, Inc. (ITOS)
Fludarabine	FATE THERAPEUTICS INC (FATE)
G-CSF	ENANTA PHARMACEUTICALS INC (ENTA)
G-CSF	Structure Therapeutics Inc. (GPCR)
G-CSF	PTC THERAPEUTICS, INC. (PTCT)
gpc-100	EXICURE, INC. (XCUR)
GPC-100	PTC THERAPEUTICS, INC. (PTCT)
GPC-100	Structure Therapeutics Inc. (GPCR)
iberdomide	CELGENE CORP /DE/ (CELG)
Ide-cel	Merus N.V. (MRUS)
imetelstat	GERON CORP (GERN)
incb001158	Incyte Corp. (INCY)
iph2101	Innate Pharma S.A. (IPHA)
iph2101	Innate Pharma SA (IPHYF)
isatuximab sc-obds	Sanofi (SNY)
LCAR-B38M CAR-T Cell	Legend Biotech Corp (LEGN)
nexi-002	NexImmune, Inc. (NEXI)
Part 1	FATE THERAPEUTICS INC (FATE)
Part 2	FATE THERAPEUTICS INC (FATE)
Plerixafor	ENANTA PHARMACEUTICALS INC (ENTA)
Pomalidomide	Crinetics Pharmaceuticals, Inc. (CRNX)
Pomalidomide	Coeptis Therapeutics Holdings Inc. (COEP)
Pomalidomide	FATE THERAPEUTICS INC (FATE)
prophylaxis a	GH Research PLC (GHRS)
prophylaxis b	GH Research PLC (GHRS)
prophylaxis c	GH Research PLC (GHRS)
prophylaxis d	GH Research PLC (GHRS)
Propranolol	Structure Therapeutics Inc. (GPCR)
Propranolol	PTC THERAPEUTICS, INC. (PTCT)
Propranolol Hydrochloride	Structure Therapeutics Inc. (GPCR)
ramantamig	GH Research PLC (GHRS)
Selinexor	FATE THERAPEUTICS INC (FATE)
Selinexor	Coeptis Therapeutics Holdings Inc. (COEP)
Talquetamab	Filana Therapeutics Inc. (FLNA)
Talquetamab	FATE THERAPEUTICS INC (FATE)
Teclistamab	Crinetics Pharmaceuticals, Inc. (CRNX)
Teclistamab	Coeptis Therapeutics Holdings Inc. (COEP)
Teclistamab	FATE THERAPEUTICS INC (FATE)
Teclistamab	Filana Therapeutics Inc. (FLNA)

Phase 1(64)

Drug	Company
ABBV-438	AbbVie Inc. (ABBV)
ABT-199	AbbVie Inc. (ABBV)
ACLX-001	Arcellx, Inc. (ACLX)
Alnuctamab	BRISTOL MYERS SQUIBB CO (BMY)
anti-bcma car-t	CELLULAR BIOMEDICINE GROUP, INC. (CMBG)
Autologous BCMA-targeting CAR T cells	Filana Therapeutics Inc. (FLNA)
Bendamustine	Filana Therapeutics Inc. (FLNA)
bl-m24d1	NYMOX PHARMACEUTICAL CORP (NYMXF)
BMS-986453	Filana Therapeutics Inc. (FLNA)
Carfilzomib	Structure Therapeutics Inc. (GPCR)
Carfilzomib	Filana Therapeutics Inc. (FLNA)
Carfilzomib	Coeptis Therapeutics Holdings Inc. (COEP)
Carfilzomib	Merus N.V. (MRUS)
CB-011	Caribou Biosciences, Inc. (CRBU)
cb-5339	CASI Pharmaceuticals, Inc (DE) (CASI)
cid-103	CASI Pharmaceuticals, Inc (DE) (CASI)
CLN-619	Cullinan Therapeutics, Inc. (CGEM)
daratumumab	Teva Pharmaceutical Industries Limited (TEVA)
Daratumumab and Recombinant Human Hyaluronidase	Coeptis Therapeutics Holdings Inc. (COEP)
diphenhydramine	Sanofi (SNY)
Efbalropendekin alfa (XmAb306 / RG6323)	Xencor Inc (XNCR)
elranatamab	C4 Therapeutics, Inc. (CCCC)
elranatamab	PFIZER INC (PFE)
Elranatamab	BRISTOL MYERS SQUIBB CO (BMY)
Etentamig	AbbVie Inc. (ABBV)
ezm0414	Epizyme, Inc. (EPZM)
fcarh143	Juno Therapeutics, Inc. (JUNO)
fludarabine	Cartesian Therapeutics, Inc. (RNAC)
FT576	FATE THERAPEUTICS INC (FATE)
Granulocyte Colony-Stimulating Factor	Merus N.V. (MRUS)
hdp-101	Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK)
hdp-101	NYMOX PHARMACEUTICAL CORP (NYMXF)
hpn217	Harpoon Therapeutics, Inc. (HARP)
iberdomide	AbbVie Inc. (ABBV)
iberdomide	PFIZER INC (PFE)
intravenous etentamig	AbbVie Inc. (ABBV)
isatuximab sar650984 iv	Sanofi (SNY)
isatuximab sar650984 sc	Sanofi (SNY)
jcarh125	Juno Therapeutics, Inc. (JUNO)
jnj-79635322	GH Research PLC (GHRS)
jnj-87562761	GH Research PLC (GHRS)
mcarh171	Juno Therapeutics, Inc. (JUNO)
mk-4002	Merck & Co., Inc. (MRK)
modakafusp alfa	Teva Pharmaceutical Industries Limited (TEVA)
nirogacestat	Allogene Therapeutics, Inc. (ALLO)
nxc-201	Immix Biopharma, Inc. (IMMX)
p-bcma-allo1	Poseida Therapeutics, Inc. (PSTX)
p-bcma-allo1 car-t cells	Poseida Therapeutics, Inc. (PSTX)
p-bcmacd19-allo1	Poseida Therapeutics, Inc. (PSTX)
phe885	NOVARTIS AG (NVSEF)
phe885	Novartis AG (NVS)
rimiducid	Poseida Therapeutics, Inc. (PSTX)
rimiducid may be administered as indicated	Poseida Therapeutics, Inc. (PSTX)
sar445514	Sanofi (SNYNF)
sar445514	Sanofi (SNY)
Selvigaltin	Coeptis Therapeutics Holdings Inc. (COEP)
Selvigaltin	FATE THERAPEUTICS INC (FATE)
shr-9539	Eiger BioPharmaceuticals, Inc. (EIGR)
sti-1492	Sorrento Therapeutics, Inc. (SRNE)
subcutaneous etentamig	AbbVie Inc. (ABBV)
TAK-079	Merus N.V. (MRUS)
tak-573	Teva Pharmaceutical Industries Limited (TEVA)
TNB-383B	AbbVie Inc. (ABBV)
tti-622	Trillium Therapeutics Inc. (TRIL)

Preclinical(7)

Drug	Company
al102	OLD AYALA, INC (AYLA)
cd38-diagnostic	COEPTIS THERAPEUTICS INC. (NDYN)
CD38-Diagnostic	Coeptis Therapeutics Holdings Inc. (COEP)
cd38-gear-nk	COEPTIS THERAPEUTICS INC. (NDYN)
CD38-GEAR-NK	Coeptis Therapeutics Holdings Inc. (COEP)
kb-9558	Kronos Bio, Inc. (KRON)
sc255	Sana Biotechnology, Inc. (SANA)

Unknown(4)

Drug	Company
HLX14	Organon & Co. (OGN)
immunomodulatory agent	GH Research PLC (GHRS)
LCAR- F33S cells intravenous infusion	Legend Biotech Corp (LEGN)
proteasome inhibitor	GH Research PLC (GHRS)

Phase 1/Phase 2(19)

Drug	Company
ABBV-453	AbbVie Inc. (ABBV)
AUTO8	Autolus Therapeutics plc (AUTL)
belantamab mafodotin	Karyopharm Therapeutics Inc. (KPTI)
Carfilzomib	BeOne Medicines Ltd. (ONC)
daratumumab	Karyopharm Therapeutics Inc. (KPTI)
daratumumab	BeOne Medicines Ltd. (ONC)
daratumumab	GENMAB A/S (GNMSF)
daratumumab	Genmab A/S (GMAB)
Daratumumab	BeOne Medicines Ltd. (ONC)
daratumumab sc	Incyte Corp. (INCY)
elotuzumab	Karyopharm Therapeutics Inc. (KPTI)
elranatamab	ASTRAZENECA PLC (AZN)
gen3014	Genmab A/S (GMAB)
gen3014	GENMAB A/S (GNMSF)
ixazomib	Karyopharm Therapeutics Inc. (KPTI)
linvoseltamab	REGENERON PHARMACEUTICALS, INC. (REGN)
mezigdomide	Karyopharm Therapeutics Inc. (KPTI)
regn17372+linvoseltamab	REGENERON PHARMACEUTICALS, INC. (REGN)
regn7945+linvoseltamab	REGENERON PHARMACEUTICALS, INC. (REGN)

Phase 2/Phase 3(2)

Drug	Company
Daratumumab	AbbVie Inc. (ABBV)
fludarabine	GH Research PLC (GHRS)

Phase 4(33)

Drug	Company
Acetaminophen	Filana Therapeutics Inc. (FLNA)
Acetaminophen	Structure Therapeutics Inc. (GPCR)
BMS-986393	BRISTOL MYERS SQUIBB CO (BMY)
cilta-cel	GH Research PLC (GHRS)
Famotidine	Filana Therapeutics Inc. (FLNA)
Famotidine	ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
Famotidine	Cidara Therapeutics, Inc. (CDTX)
Famotidine	Structure Therapeutics Inc. (GPCR)
Famotidine	PROTHENA CORP PUBLIC LTD CO (PRTA)
ixazomib	TAKEDA PHARMACEUTICAL CO LTD (TKPHF)
ixazomib	Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK)
Loratadine	Structure Therapeutics Inc. (GPCR)
Loratadine	Filana Therapeutics Inc. (FLNA)
Loratadine	ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
Loratadine	Cidara Therapeutics, Inc. (CDTX)
Montelukast	Cidara Therapeutics, Inc. (CDTX)
Montelukast	ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
Montelukast	Filana Therapeutics Inc. (FLNA)
Montelukast	PROTHENA CORP PUBLIC LTD CO (PRTA)
Motixafortide	Cidara Therapeutics, Inc. (CDTX)
Motixafortide	PROTHENA CORP PUBLIC LTD CO (PRTA)
Motixafortide	Structure Therapeutics Inc. (GPCR)
Motixafortide	ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
Motixafortide	Filana Therapeutics Inc. (FLNA)
mRNA-2808	Moderna, Inc. (MRNA)
ogsiveo	SpringWorks Therapeutics, Inc. (SWTX)
Olanzapine	Merus N.V. (MRUS)
Recombinant Granulocyte Colony-Stimulating Factor	ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
Recombinant Granulocyte Colony-Stimulating Factor	Filana Therapeutics Inc. (FLNA)
Recombinant Granulocyte Colony-Stimulating Factor	PROTHENA CORP PUBLIC LTD CO (PRTA)
Siltuximab	ENANTA PHARMACEUTICALS INC (ENTA)
teclistamab	JOHNSON & JOHNSON (JNJ)
tocilizumab	REGENERON PHARMACEUTICALS, INC. (REGN)

Compare drugs

abecma vs bortezomib abecma vs carmustine abecma vs clonoSEQ

Frequently asked questions

How many drugs are in development for Multiple Myeloma?

BioSniper tracks 267 drugs in development for Multiple Myeloma across 77 companies.

How many clinical trials target Multiple Myeloma?

There are 144 clinical trials targeting Multiple Myeloma tracked by BioSniper.

What is the prevalence of Multiple Myeloma?

The estimated prevalence of Multiple Myeloma is approximately 17.0 per 100,000 population.

Deep-dive into Multiple Myeloma

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis